Tech Company Financing Transactions
InnovHeart Funding Round
InnovHeart, based in Milano, received $55 million in investment from Grand Pharmaceutical, Genextra S.p.A. and Indaco Venture Partners.
Transaction Overview
Company Name
Announced On
2/4/2022
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
Grand Pharmaceutical (Lead Investor)
Genextra S.p.A. (Federica Draghi)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Via Giovannino de Grassi 11
Milano, MA 20123
Italy
Milano, MA 20123
Italy
Phone
Undisclosed
Website
Email Address
Overview
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Keith Dawkins
Browse more venture capital transactions:
Prev: 2/4/2022: Alva Labs venture capital transaction
Next: 2/4/2022: Descartes Underwriting venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs